id | C00018711 |
---|---|
Name | Cerulenin / Helicocerin / (+)-Cerulenin |
CAS RN | 17397-89-6 |
Standard InChI | InChI=1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15)/b3-2+,6-5+/t10-,11-/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15) |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 8847 |
By standard InChI | CHEMBL45627 |
---|---|
By standard InChI Main Layer | CHEMBL45627 CHEMBL2000322 |
By LinkDB | C12058 |
---|
By CAS RN | D002569 |
---|
class name | count |
---|
family name | count |
---|
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Cephalosporium caerulens | 150420 | Fungi |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL45627 |
CHEMBL1613842
(1)
|
4 / 2 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL45627 |
CHEMBL1613818
(1)
|
6 / 4 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL45627 |
CHEMBL1614554
(1)
|
3 / 1 |
P49327 | Fatty acid synthase | Transferase | CHEMBL45627 |
CHEMBL873666
(1)
CHEMBL862461
(1)
CHEMBL960231 (1) CHEMBL985841 (1) CHEMBL1839595 (1) CHEMBL2169042 (1) |
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL45627 |
CHEMBL1794311
(1)
|
2 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL45627 |
CHEMBL1614458
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL45627 |
CHEMBL1614250
(1)
CHEMBL1614421
(1)
|
4 / 3 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL45627 |
CHEMBL1738442
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D002569 | 83939 |
EIF2A
EIF-2A MST089 MSTP004 MSTP089 |
eukaryotic translation initiation factor 2A, 65kDa | Cerulenin results in increased phosphorylation of EIF2A protein |
increases phosphorylation
|
protein |
17283163
|
D002569 | 2081 |
ERN1
IRE1 IRE1P IRE1a hIRE1p |
endoplasmic reticulum to nucleus signaling 1 (EC:2.7.11.1) | Cerulenin affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA] |
affects reaction
/ affects splicing |
protein |
17283163
|
D002569 | 2194 |
FASN
FAS OA-519 SDR27X1 |
fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) | Cerulenin results in decreased activity of FASN protein |
decreases activity
|
protein |
12798352
|
D002569 | 2194 |
FASN
FAS OA-519 SDR27X1 |
fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) | [Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine |
decreases abundance
/ decreases activity |
protein |
18723500
|
D002569 | 3172 |
HNF4A
HNF4 HNF4a7 HNF4a8 HNF4a9 HNF4alpha MODY MODY1 NR2A1 NR2A21 TCF TCF14 |
hepatocyte nuclear factor 4, alpha | Cerulenin inhibits the reaction [Fructose results in decreased expression of HNF4A mRNA] |
decreases expression
/ decreases reaction |
mRNA |
17992261
|
D002569 | 3172 |
HNF4A
HNF4 HNF4a7 HNF4a8 HNF4a9 HNF4alpha MODY MODY1 NR2A1 NR2A21 TCF TCF14 |
hepatocyte nuclear factor 4, alpha | Cerulenin inhibits the reaction [Glucose results in decreased expression of HNF4A mRNA] |
decreases expression
/ decreases reaction |
mRNA |
17992261
|
D002569 | 6462 |
SHBG
ABP SBP TEBG |
sex hormone-binding globulin | Cerulenin inhibits the reaction [Fructose results in decreased expression of SHBG protein] |
decreases expression
/ decreases reaction |
protein |
17992261
|
D002569 | 6462 |
SHBG
ABP SBP TEBG |
sex hormone-binding globulin | Cerulenin inhibits the reaction [Glucose results in decreased expression of SHBG protein] |
decreases expression
/ decreases reaction |
protein |
17992261
|
D002569 | 7494 |
XBP1
TREB5 XBP-1 XBP2 |
X-box binding protein 1 | Cerulenin affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA] |
affects reaction
/ affects splicing |
mRNA |
17283163
|
OMIM | preferred title | UniProt |
---|---|---|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | disease name | UniProt |
---|---|---|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |